Yusuke Okuma

42PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Oct 29, 2026
Longitudinal plasma osimertinib concentrations during treatment in patients with EGFR-mutant NSCLC: a prospective real-world study.

|Jun 29, 2026
Pharmacokinetic variability with pembrolizumab dosage switching and its impact on immune-related adverse events in patients with non-small cell lung cancer.

|Jun 02, 2026
Role of VEGFA/VEGFR2 signaling in predicting clinical outcomes of EGFR-TKI treatment in EGFR-mutant non-small cell lung cancer.

|Feb 11, 2026
Immune checkpoint inhibitors in nuclear protein in testis carcinoma treatment: evidence of limited clinical benefits from a case series.

Tomoaki Nakamura, Tatsuya Yoshida, Akihiko Yoshida

|Aug 15, 2025
Effects of Sarcopenia on the Outcomes and Safety of Chemoradiotherapy Followed by Durvalumab for the Treatment of Patients With Locally Advanced Non-Small Cell Lung Cancer.

Kentaro Tamura, Hidehito Horinouchi, Mototaka Miyake

|Jun 12, 2025
An update on the therapeutic options for metastatic thymomas and thymic carcinomas.

Yoshihiro Masui, Yusuke Okuma

Pageof 7

Frequent Collaborators

10 joint publications

Hidehito Horinouchi

9 joint publications

Tatsuya Yoshida

4 joint publications

Noriko Motoi

4 joint publications

Yasushi Goto